IRIS
DE BARTOLOMEIS, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.665
NA - Nord America 9.620
EU - Europa 6.262
SA - Sud America 1.328
Continente sconosciuto - Info sul continente non disponibili 400
AF - Africa 281
OC - Oceania 9
Totale 27.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.209
SG - Singapore 4.207
RU - Federazione Russa 2.687
CN - Cina 1.970
VN - Vietnam 1.640
IT - Italia 1.461
BR - Brasile 1.059
HK - Hong Kong 738
DE - Germania 429
FR - Francia 315
BD - Bangladesh 260
FI - Finlandia 254
CA - Canada 220
GB - Regno Unito 213
NL - Olanda 202
UA - Ucraina 178
IE - Irlanda 153
JP - Giappone 149
IN - India 116
KR - Corea 106
MX - Messico 104
CI - Costa d'Avorio 100
AR - Argentina 92
SE - Svezia 90
ES - Italia 62
IQ - Iraq 57
ZA - Sudafrica 56
ID - Indonesia 54
PL - Polonia 50
EC - Ecuador 48
PH - Filippine 44
TR - Turchia 44
AT - Austria 43
TH - Thailandia 42
PK - Pakistan 37
CO - Colombia 33
TW - Taiwan 30
VE - Venezuela 27
MA - Marocco 26
JM - Giamaica 23
CL - Cile 22
AE - Emirati Arabi Uniti 20
BE - Belgio 16
PY - Paraguay 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
LT - Lituania 15
PE - Perù 15
HU - Ungheria 14
MY - Malesia 14
EG - Egitto 13
JO - Giordania 13
KE - Kenya 12
TN - Tunisia 11
ET - Etiopia 10
HN - Honduras 10
IR - Iran 10
BG - Bulgaria 9
DZ - Algeria 9
CR - Costa Rica 8
IS - Islanda 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
IL - Israele 7
KZ - Kazakistan 7
LB - Libano 7
GR - Grecia 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
NG - Nigeria 6
NI - Nicaragua 6
OM - Oman 6
SI - Slovenia 6
AL - Albania 5
AO - Angola 5
AU - Australia 5
AZ - Azerbaigian 5
NP - Nepal 5
PT - Portogallo 5
SV - El Salvador 5
BO - Bolivia 4
BS - Bahamas 4
BY - Bielorussia 4
CH - Svizzera 4
GE - Georgia 4
MN - Mongolia 4
QA - Qatar 4
RO - Romania 4
BB - Barbados 3
BW - Botswana 3
CM - Camerun 3
CY - Cipro 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
MK - Macedonia 3
NO - Norvegia 3
PA - Panama 3
PR - Porto Rico 3
Totale 27.090
Salva come PNG Salva come JPEG
Città #
Singapore 1.971
San Jose 1.843
Hong Kong 704
Moscow 669
Ashburn 653
Beijing 566
Chandler 444
Ho Chi Minh City 444
Hefei 419
Hanoi 385
Santa Clara 357
Naples 322
Council Bluffs 243
Los Angeles 222
The Dalles 219
Lauterbourg 204
Millbury 204
Jacksonville 180
Princeton 147
New York 143
Amsterdam 142
Buffalo 121
Munich 118
Tokyo 118
Dallas 116
Nanjing 115
Boston 101
São Paulo 101
Houston 99
Rome 98
Phoenix 93
Wilmington 88
Redondo Beach 84
Norwalk 80
Des Moines 77
Seoul 76
Frankfurt am Main 75
Da Nang 71
Haiphong 69
Seattle 69
Milan 64
Ottawa 63
Atlanta 56
Napoli 56
Chicago 54
Turku 54
Nuremberg 52
Orem 52
Brooklyn 51
Mexico City 51
Helsinki 49
San Francisco 48
Nanchang 45
Denver 43
London 42
Montreal 41
Woodbridge 41
Toronto 35
Lawrence 34
Rio de Janeiro 33
Catania 32
Shenyang 31
Changsha 29
Falkenstein 29
Hebei 27
Warsaw 27
Belo Horizonte 26
Chennai 25
Johannesburg 25
Biên Hòa 24
Dong Ket 24
Jiaxing 24
Hải Dương 22
Baghdad 21
Boardman 21
Dhaka 21
Stockholm 21
Brasília 20
Can Tho 20
Falls Church 20
Kronberg 20
Ankara 18
Poplar 18
Quito 18
Curitiba 17
Dublin 17
Lappeenranta 17
Bangkok 16
Düsseldorf 16
New Delhi 16
Portici 16
Salvador 16
Shanghai 16
Thái Nguyên 16
Bari 15
Philadelphia 15
Tianjin 15
Barcelona 14
Brussels 14
Guangzhou 14
Totale 14.027
Salva come PNG Salva come JPEG
Nome #
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” 592
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 377
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal 289
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 205
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 202
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 192
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 186
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials 185
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 179
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 175
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 173
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 171
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 171
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 169
Cognitive correlates of borderline intellectual functioning in borderline personality disorder 167
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 166
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 165
Atypical depression and emotion dysregulation: Clinical and psychopathological features 162
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials 160
Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance 157
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 157
Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia 155
Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia 155
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 155
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach 154
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice 150
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 150
Transcranial direct current stimulation for obsessive–compulsive disorder: A randomized, controlled, partial crossover trial 149
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 149
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 148
Corrigendum to “Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity” [Eating Behaviors volume 57 (April 2025), Online ahead of print, 101961] 146
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 146
Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study 145
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment 144
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 143
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia 141
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 141
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 140
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction 140
Psychiatric Symptoms in Parkinson’s Disease Patients before and One Year after Subthalamic Nucleus Deep Brain Stimulation Therapy: Role of Lead Positioning and Not of Total Electrical Energy Delivered 139
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review 138
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 137
Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors 137
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 136
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine 136
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 136
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 136
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study 136
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 135
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 135
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. 135
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 135
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 132
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 131
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 131
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 130
The Role of Astrocytes in the Molecular Pathophysiology of Schizophrenia: Between Neurodevelopment and Neurodegeneration 130
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 129
Homelessness and health-related outcomes: an umbrella review of observational studies and randomized controlled trials 129
Acute administration of antipsychotics modulates Homer striatal gene expression differentially 129
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 128
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 128
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 128
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 128
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 128
Perinatal stress modulates glutamatergic functional connectivity: A post-synaptic density immediate early gene-based network analysis 127
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis 127
Mental health during the 2022 Russo-Ukrainian War: A scoping review and unmet needs 127
d-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice 127
Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder 127
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 127
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review 126
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 126
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted 126
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 125
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 125
Severity of autism-related symptoms in treatment-resistant schizophrenia: associations with cognitive performance, psychosocial functioning, and neurological soft signs - Clinical evidence and ROC analysis 125
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 125
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 125
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 125
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 124
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 124
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 124
A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration 124
Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates 123
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation 123
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 123
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 123
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 122
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 122
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 122
Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment 121
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 120
Dandy-Walker Syndrome with psychotic symptoms: A case report 120
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 120
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight 120
Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials 119
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 119
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment 119
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 118
Totale 14.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022956 0 0 8 11 8 48 22 32 162 79 163 423
2022/20231.187 193 95 35 49 138 160 14 108 159 103 89 44
2023/20241.016 33 146 92 92 59 51 60 161 35 26 168 93
2024/20256.460 322 423 16 55 170 320 717 444 487 653 2.222 631
2025/202613.692 1.487 1.048 1.444 1.050 2.208 512 1.641 726 1.658 923 438 557
2026/20272.148 506 1.034 608 0 0 0 0 0 0 0 0 0
Totale 27.565